Clinical Trials Browser

Uveal Melanoma, Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Sarcoma

NCT05170334 2025-10-01

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

Phase 2 Active not recruiting

7 enrolled

Dermatologic

Uveal Melanoma, Eye Neoplasms

NCT04283890 2025-09-09

CHOPIN

Phase 1/2 Active not recruiting

83 enrolled

Dermatologic

Uveal Melanoma, Neoplasm Metastasis

NCT04588662 2025-08-22

A Prospective Natural History Study in Uveal Melanoma

Active not recruiting

122 enrolled

Dermatologic

Uveal Melanoma

NCT04728633 2025-08-06

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Phase 2 Active not recruiting

28 enrolled

Dermatologic

Uveal Melanoma

NCT05341349 2025-07-30

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Phase 1 Active not recruiting

1 enrolled

CNSDermatologic

Uveal Melanoma, Brain Neoplasms, Melanoma

NCT05308901 2025-07-25

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

Phase 2 Active not recruiting

6 enrolled 11 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT05415072 2025-07-20

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

Phase 1/2 Active not recruiting

66 enrolled

Dermatologic

Uveal Melanoma, Eye Neoplasms, Melanoma, Neoplasms

NCT05315258 2025-07-17

TebeMRD

Phase 2 Active not recruiting

850 enrolled

Dermatologic

Uveal Melanoma, Melanoma

NCT05187884 2025-06-24

NADOM

Phase 2 Active not recruiting

15 enrolled

Dermatologic

Uveal Melanoma

NCT06863870 2025-03-07

Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma

Active not recruiting

35 enrolled

Dermatologic

Uveal Melanoma

Clinical Trials

Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Study of RP2 Monotherapy and RP2 in Combination With Nivolumab in Patients With Solid Tumors

PROMPT

DIET

OCULE-01

Psychoeducation for Uveal Melanoma

Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease

Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

PLUME

Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma

A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

CHOPIN

A Prospective Natural History Study in Uveal Melanoma

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal Melanoma

A Phase I/II Study of DYP688 in Patients With Metastatic Uveal Melanoma and Other GNAQ/11 Mutant Melanomas

TebeMRD

NADOM

Assessment of Circulating Tumor Cells and microRNAs in Patients With Metastatic Non-cutaneous Melanoma